Atara Biotherapeutics's total assets for Q3 2024 were $142.71M, an increase of 21.68% from the previous quarter. ATRA total liabilities were $233.25M for the fiscal quarter, a 2.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.